A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2002
11/07/2002	US20020164366 Transdermal delivery system
11/07/2002	US20020164360 Topical applying peptide to skin
11/07/2002	US20020164349 Induction apoptosis; west nile virus therapy
11/07/2002	US20020164347 Neoglycoproteins
11/07/2002	US20020164345 Compositions and methods for the therapy and diagnosis of colon cancer
11/07/2002	US20020164344 Anticancer agents; vaccines
11/07/2002	US20020164339 Recombinant peptides derived from the Mc3 anti-BA46 antibody, methods of use thereof, and methods of humanizing antibody peptides
11/07/2002	US20020164336 Combination anti-selectin and immunosuppressant therapy
11/07/2002	US20020164334 Antibody-induced apoptosis
11/07/2002	US20020164332 Mammalian cytokines; related reagents and methods
11/07/2002	US20020164330 Novel molecules of the tango-77 related protein family and uses thereof
11/07/2002	US20020164329 Adsorption and removal of endotoxin from physiological fluids using cationic helix peptides
11/07/2002	US20020164325 Regeneration of axons; central nervous systewm disorders
11/07/2002	US20020164323 Antithrombin; antiinflammatory agents, rheumatic diseases
11/07/2002	US20020164321 Compositions and methods for treating retroviral infections
11/07/2002	US20020164319 Medical use of matrix metalloproteinase inhibitors for inhibiting tissue contraction
11/07/2002	US20020164316 Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
11/07/2002	US20020164311 Prevention of organ rejection
11/07/2002	US20020164310 Nucleic acid constructs, cells transformed therewith and methods utilizing same for inducing liver regeneration and alleviation of portal hypertension
11/07/2002	US20020164305 Integrin fusion protein; binding to antibodies
11/07/2002	US20020164303 Administering nucleic acids to muscle tissue
11/07/2002	US20020164302 Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof
11/07/2002	US20020164301 Methods for inhibiting atherosclerotic plaque formation
11/07/2002	US20020164300 Interleukin-2 mutein expressed from mammalian cells
11/07/2002	US20020164299 Moderator of gene expression
11/07/2002	US20020164287 Azo compounds for type i phototherapy
11/07/2002	US20020164267 Preventing immunologically mediated beta cell failure prior to or after the onset of Type 2 diabetes with inhaled insulin, by administering to a human patient in need of such prevention, an effective amount of inhaled insulin
11/07/2002	US20020162550 Sugarcane fractioning system
11/07/2002	DE10129870A1 Antibakterielles Mittel Antibacterial agent
11/07/2002	DE10121255A1 Use of alpha 1-antichymotrypsin polypeptide or nucleic acids encoding the polypeptide, or of a cell expressing the polypeptide, or of antibody against the polypeptide, for diagnosing, treating or preventing poorly-healing wounds
11/07/2002	DE10121254A1 Functional assay on the activity of human MRP8/MRP14 heterodimer, for diagnosing and treating skin diseases, wounds or wound-healing disturbances with reduced quantity of the heterodimer, in particular a diabetic ulcer
11/07/2002	DE10109897A1 Fakultativ kationische Liposomen und Verwendung dieser Optional cationic liposomes and use of these
11/07/2002	CA2821193A1 Prevention of myocardial infarction induced ventricular expansion and remodeling
11/07/2002	CA2449794A1 Alleviation of the memory deficits and memory components of psychiatric dysfunctions by altering atypical pkm activity
11/07/2002	CA2448607A1 Colloidal metal compositions and methods
11/07/2002	CA2448580A1 Compositions for treating animal diseases and syndromes
11/07/2002	CA2446761A1 Medical device
11/07/2002	CA2446408A1 Recombinant mhc molecules useful for manipulation of antigen-specific t-cells
11/07/2002	CA2446101A1 Raav-vectored ribozyme compositions and methods for the treatment of retinal diseases
11/07/2002	CA2446079A1 Modulators of elastase inhibitor secretion
11/07/2002	CA2446023A1 Cell adhesion and extracellular matrix proteins
11/07/2002	CA2446010A1 Production of the lantibiotic cinnamycin with genes isolated from streptomyces cinnamoneus
11/07/2002	CA2445995A1 Antibacterial agent
11/07/2002	CA2445978A1 Antigens of group b streptococcus and corresponding dna fragments
11/07/2002	CA2445974A1 Immunogenic tumor antigens: nucleic acids and polypeptides encoding the same and methods of use thereof
11/07/2002	CA2445967A1 Compositions comprising lopinavir and methods for enhancing the bioavailability of pharmaceutical agents
11/07/2002	CA2445860A1 Pharmaceutical composition including ace/nep inhibitors and bioavailability enhancers
11/07/2002	CA2445847A1 A molecular marker
11/07/2002	CA2445827A1 P450 proteins
11/07/2002	CA2445811A1 Modified fvii in treatment of ards
11/07/2002	CA2445702A1 Control of compactability through crystallization
11/07/2002	CA2445532A1 Breast cancer-associated genes and uses thereof
11/07/2002	CA2445410A1 Ovary-specific genes and proteins
11/07/2002	CA2445373A1 Use of phyllanthus constituents for treating or preventing infections caused by hepatitis b viruses
11/07/2002	CA2445343A1 Use of protein and essential amino acids to treat amenorrhea and related disorders
11/07/2002	CA2445338A1 G-protein coupled receptors
11/07/2002	CA2445298A1 Use of agt and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions
11/07/2002	CA2445290A1 A pharmaceutical tablet having a high api content
11/07/2002	CA2445266A1 Foot and mouth disease virus vaccine
11/07/2002	CA2444911A1 Fusion molecules and methods for treatment of immune diseases
11/07/2002	CA2444727A1 Agents for preventing postoperative recurrence of premenopausal breast cancer
11/07/2002	CA2444504A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
11/07/2002	CA2443719A1 Human fibroblast growth factor-related compositions
11/07/2002	CA2443393A1 Polynucleotide encoding a novel cysteine protease of the calpain superfamily, can-12, and variants thereof
11/07/2002	CA2440775A1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use
11/07/2002	CA2408127A1 Stabilised enzyme compositions
11/06/2002	EP1255109A1 Screening method
11/06/2002	EP1254961A1 Improvments in gene therapy using compositions comprising a polynucleotide and interleukin-10
11/06/2002	EP1254956A2 Novel osteoinductive compositions
11/06/2002	EP1254952A1 Cells capable of differentiating into heart muscle cells
11/06/2002	EP1254912A1 Cyk-4 polypeptides, DNA molecules encoding them and their use in screening methods
11/06/2002	EP1254898A1 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
11/06/2002	EP1254665A1 Use of albumin alone or in combination with growth factors for inhibiting apoptosis
11/06/2002	EP1254663A1 Anti-virus agent
11/06/2002	EP1254270A1 Methods and materials relating to cub domain polypeptides and polynucleotides
11/06/2002	EP1254269A1 Methods and materials relating to neuronal guidance molecule-like (ngm-like) polypeptides and polynucleotides
11/06/2002	EP1254268A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
11/06/2002	EP1254267A1 Compositions and methods for the early diagnosis of ovarian cancer
11/06/2002	EP1254266A1 Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides
11/06/2002	EP1254265A1 Methods and materials relating to metallocarboxypeptidase-like polypeptides and polynucleotides
11/06/2002	EP1254264A1 Human protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
11/06/2002	EP1254259A1 Antisense modulation of pepck-cytosolic expression
11/06/2002	EP1254256A2 Novel nucleic acids and polypeptides
11/06/2002	EP1254255A1 Trefoil domain-containing polynucleotides, polypeptides, and antibodies
11/06/2002	EP1254248A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254247A1 Protein and oat beta glucan hydrolysate for use in cosmetology and method for making same
11/06/2002	EP1254246A1 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides
11/06/2002	EP1254242A1 17 human secreted proteins
11/06/2002	EP1254241A2 Phosphatases
11/06/2002	EP1254240A2 Proteins producing an altered immunogenic response and methods of making and using the same
11/06/2002	EP1254239A2 Mammalian secreted group iii phospholipase a2
11/06/2002	EP1254237A2 Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
11/06/2002	EP1254236A2 Drug metabolizing enzymes
11/06/2002	EP1254235A2 Drug metabolizing enzymes
11/06/2002	EP1254231A1 Genes encoding abc1 paralogs and the polypeptides derived therefrom
11/06/2002	EP1254229A1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof
11/06/2002	EP1254227A2 Fusion receptor from tnf family
11/06/2002	EP1254225A2 Novel family of proteins, called atip, nucleic sequences coding for same and uses thereof
11/06/2002	EP1254224A2 Interferon-alpha induced genes
11/06/2002	EP1254223A1 Cysteinyl leukotriene receptor 2 (cyslt2)

1 ... 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 ... 3163